SEC Form 4 · accession 0001479791-18-000005
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Jan 11, 2018
Accepted (ET)
Jan 12, 2018 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Jan 11, 2018 | S | 5,100 | $0.15 | D | 25,570,663 | D | |
| INVO Bioscience Common Stock | Jan 12, 2018 | S | 7,445 | $0.145 | D | 25,563,218 | D |
Table II — derivative securities
No Table II lines on this filing.